middle.news
Can PYC-001 Restore Vision? Early Data Show Promise in Rare Eye Disease
9:12am on Friday 5th of September, 2025 AEST
•
Healthcare
Read Story
Can PYC-001 Restore Vision? Early Data Show Promise in Rare Eye Disease
9:12am on Friday 5th of September, 2025 AEST
Key Points
Completed dosing in Phase 1 Single Ascending Dose study of PYC-001
No serious adverse events reported in treated patients
Early indications of improved visual acuity in treated eyes
Presentation of clinical data scheduled for NOSA 2025 conference
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pyc Therapeutics (ASX:PYC)
OPEN ARTICLE